N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), A Novel, Orally Effective Vanilloid Receptor 1 Antagonist With Analgesic Properties: I. In Vitro Characterization And Pharmacokinetic Properties
Kenneth J. Valenzano, Elfrida R. Grant, Gang Wu, Mohamed Hachicha, Lori Schmid, Laykea Tafesse, Qun Sun, Yakov Rotshteyn, Joseph Francis, James Limberis, Shiazah Malik, Edward R. Whittemore, Dianne Hodges
Twitter
Facebook
LinkedIn
Email